Harrow Health share price logo

Harrow Health

NASDAQ: HROW

Small Cap

$30.62

+0.27

(+0.89%)

as on

Harrow Health Stock Performance

as on October 8, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $29.90
    $31.11
    downward going graph

    2.35%

    Downside

    1.60%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $28.54
    $54.85
    downward going graph

    6.79%

    Downside

    79.13%

    Upside

    downward going graph

Harrow Health share price movements today

Previous Close
$30.35
Open
$29.91
Volume
711.3K
Market Cap
$1.1B
Day's Low - High
$29.90 - $31.11
52 Week Low - High
$28.54 - $54.85

Harrow Health Historical Returns

1 Month Return
-19.1 %
3 Month Return
-32.06 %
1 Year Return
-22.95 %
3 Year Return
+ 114.58 %
5 Year Return
+ 217.31 %

Harrow Health Stock Fundamentals & Key Indicators

Check Harrow Health market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.1B

EPS (TTM)

-0.9925

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.10%

PE Ratio (TTM)

-30.58

Industry PE ratio

2.37

PEG Ratio

0.56

EBITDA

4.5M

Revenue (TTM)

275.6M

Profit Margin

73.28%

Return On Equity TTM

-103.86%

Harrow Health vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Harrow Health with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Harrow Health image
Harrow Health
StrongBuy$1.1B217.31%-30.5873.28%0.00%
Sandoz Group Ltd Sponsored ADR image
Sandoz Group Ltd Sponsored ADR
Buy$37.0BNA56.2447.54%1.22%
United Therapeutics image
United Therapeutics
Buy$23.2B178.94%17.9286.14%0.00%
Viatris image
Viatris
Buy$20.2B28.69%-48.9434.83%2.72%
Haleon PLC Sponsored ADR image
Haleon PLC Sponsored ADR
Buy$38.6BNA18.4165.57%2.23%
See all

Stock Returns calculator for Harrow Health Stock including INR - Dollar returns

The Harrow Health stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Harrow Health investment value today

Current value as on today

₹84,028

Returns

-₹15,972

(-15.97%)

Returns from Harrow Health Stock

-₹22,949 (-22.95%)

Dollar Impact

₹6,977 (+6.98%)

Analyst Recommendation on Harrow Health Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Harrow Health. Average target price of $65

Harrow Health Share Price Target

Get share price movements and forecasts by analysts on Harrow Health.

What analysts predicted

52.89%UPSIDE

Target Price

$65

Current Price

$30.62

Analyzed by

5 Analysts

High

$88

Target

$65.00

Low

$60

Harrow Health target price $65, a slight upside of 52.89% compared to current price of $30.62. According to 5 analysts rating.

Indian Investors' Interest in Harrow Health Stock

Search interest for Harrow Health Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-45% versus previous 30 day period

Harrow Health Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
34
48
49
66
47
63
71
89
44
70
Gross Profit
24
36
37
52
32
47
53
70
27
50
Operating Income
-6
1
1
12
-11
11
14
24
-22
-11
EBITDA
-5
2
4
17
-6
15
11
20
-16
-11
Interest Expense
5
5
5
6
6
6
6
5
5
6
Depreciation
2
2
2
4
4
4
4
4
5
-
Income Before Tax
-13
-5
-4
6
-17
4
1
10
-27
-17
Income Tax Expense
-
0
0
0
-
-
-
3
0
-
Net Income
-13
-6
-4
6
-17
4
1
6
-27
-17
Net Profit Margin
69.49%
74.38%
75.60%
78.85%
67.54%
74.54%
75.28%
79.27%
61.18%
71.27%

Harrow Health Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
26
41
51
48
72
88
130
199
272
Gross Profit
13
24
34
34
54
63
90
150
204
Operating Income
-12
-5
-4
0
1
1
0
8
38
EBITDA
-10
-3
1
2
5
-3
11
22
41
Interest Expense
3
2
2
2
5
7
21
22
24
Depreciation
1
1
2
1
1
2
11
13
18
Income Before Tax
-12
14
0
-3
-17
-14
-23
-17
-1
Income Tax Expense
0
-
0
0
0
0
0
0
3
Net Income
-11
14
0
-3
-18
-14
-24
-17
-5
Net Profit Margin
49.56%
60.07%
67.26%
70.41%
74.87%
71.35%
69.55%
75.33%
75.05%

Harrow Health Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-13
-6
-4
6
-17
4
1
6
-27
27
Operating Cash Flow
-4
-2
2
-17
19
0
16
8
-8
-9
Investing Cash Flow
0
5
0
-37
0
0
0
-4
-18
0
Financing Cash Flow
0
0
0
29
0
-12
4
-5
48
0
Change in Cash
-5
2
1
-25
19
-13
21
-1
21
-10

Harrow Health Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-11
14
0
-3
-18
-14
-24
-17
-5
Operating Cash Flow
-8
0
0
-1
5
1
3
-22
43
Investing Cash Flow
0
-2
-1
0
-18
-1
-152
-33
-5
Financing Cash Flow
4
4
-1
1
51
54
126
28
-12
Change in Cash
-4
2
-1
0
37
54
-22
-26
25

Global Institutional Holdings in Harrow Health

Check out the Institutions with significant holdings in Harrow Health.

Funds
Holdings
Vanguard
4.55%
Gregg Powers
4.26%
iShares
4.16%
VANGUARD INDEX FUNDS
3.65%
SPDR
1.04%
See all

Insights on Harrow Health

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, HROW has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 44.20M → 70.66M (in $), with an average increase of 37.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -27.60M → -17.27M (in $), with an average increase of 59.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Viatris Inc. Common Stock has given 75.4% return, outperforming this stock by 98.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, HROW stock has moved down by -19.1%

About Harrow Health

Harrow Health, Inc. operates as a healthcare enterprise with a specialized focus on ophthalmic solutions. The company's portfolio includes ImprimisRx, a business dedicated to ophthalmology outsourcing and pharmaceutical compounding, as well as DEXYCU, a product utilized for managing post-operative inflammation. Beyond its direct offerings, Harrow Health maintains equity investments in several pharmaceutical ventures. These encompass Surface Ophthalmics, Inc., a clinical-stage firm actively developing and commercializing therapeutic agents for ocular surface diseases; Melt Pharmaceuticals, Inc., another clinical-stage entity concentrating on proprietary non-intravenous sedation and anesthesia treatments for various medical procedures conducted in hospital, outpatient, and office environments; and Eton Pharmaceuticals, Inc., a commercial-stage company involved in the creation and market launch of drug products. Moreover, Harrow Health holds royalty interests in four investigational drug candidates currently being advanced by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company, initially incorporated in 2006 and based in San Diego, California, underwent a name change from Imprimis Pharmaceuticals, Inc. to Harrow Health, Inc. in December 2018.
OrganisationHarrow Health
Headquarters1A Burton Hills Boulevard, Nashville, TN, 37215, US
IndustryDrug Manufacturers - Specialty & Generic
CEOMark L. Baum

Key Management of Harrow Health

Name

Title

Mr. Mark L. Baum J.D.

CEO, Chairman of the Board & Founder

Dr. Amir W. Shojaei Ph.D., Pharm.D.

Chief Scientific Officer

Mr. Francis W. Mullery

President & CEO of Harrow's ImprimisRx Division

Mr. Brett A. Burrell

Vice President of Legal & Compliance

Ms. Kim Barratt

Chief Talent Officer

Dr. Mark A. Mannebach Ph.D., R.Ph.

Head of Regulatory Affairs & Pharmacovigilance

Mr. Patrick W. Sullivan

Chief Commercial Officer

Mr. Andrew R. Boll C.F.A., C.M.A.

President, CFO & Chief Accounting Officer

Mr. Michael D. Biega

Vice President of Investor Relations & Communications

Dr. Prashanth S. Annavajjhala

Chief of Staff

FAQs

What is Harrow Health share price today?

Harrow Health share price today is $30.62 as on at the close of the market. Harrow Health share today touched a day high of $31.11 and a low of $29.90.

What is the 52 week high and 52 week low for Harrow Health share?

Harrow Health share touched a 52 week high of $54.85 on and a 52 week low of $28.54 on . Harrow Health stock price today i.e. is closed at $30.62,which is 44.18% down from its 52 week high and 7.29% up from its 52 week low.

What is Harrow Health's market capitalisation today?

Harrow Health market capitalisation is $0.00T as on .

How to invest in Harrow Health Stock (HROW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Harrow Health on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Harrow Health Stock (HROW) from India?

Indian investors can start investing in Harrow Health (HROW) shares with as little as ₹96.775001525879 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.75 in Harrow Health stock (as per the Rupee-Dollar exchange rate as on ). Based on Harrow Health share’s latest price of $30.62 as on October 8, 2026 at 8:45 am IST, you will get 0.3266 shares of Harrow Health. Learn more about fractional shares .

What are the returns that Harrow Health has given to Indian investors in the last 5 years?

Harrow Health stock has given 217.31% share price returns and 28.7% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?